MKS Instruments (NASDAQ:MKSI) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Friday.

A number of other brokerages also recently issued reports on MKSI. Dougherty & Co lifted their price target on shares of MKS Instruments from $106.00 to $115.00 and gave the stock a “buy” rating in a research note on Thursday, October 26th. Deutsche Bank boosted their price objective on shares of MKS Instruments from $104.00 to $116.00 and gave the company a “buy” rating in a research note on Thursday, October 26th. Stifel Nicolaus reissued a “buy” rating and issued a $108.00 price objective (up from $98.00) on shares of MKS Instruments in a research note on Tuesday, October 24th. KeyCorp reissued an “outperform” rating and issued a $100.00 price objective on shares of MKS Instruments in a research note on Saturday, September 16th. Finally, BidaskClub upgraded shares of MKS Instruments from a “buy” rating to a “strong-buy” rating in a research report on Thursday, August 17th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. MKS Instruments has an average rating of “Buy” and an average price target of $109.75.

Shares of MKS Instruments (MKSI) opened at $93.45 on Friday. MKS Instruments has a 12-month low of $53.51 and a 12-month high of $110.60. The firm has a market cap of $5,073.87, a PE ratio of 17.67, a price-to-earnings-growth ratio of 1.01 and a beta of 1.05. The company has a debt-to-equity ratio of 0.29, a quick ratio of 3.10 and a current ratio of 4.23.

MKS Instruments (NASDAQ:MKSI) last posted its quarterly earnings data on Tuesday, October 24th. The scientific and technical instruments company reported $1.56 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.46 by $0.10. MKS Instruments had a net margin of 16.97% and a return on equity of 21.21%. The business had revenue of $486.27 million during the quarter, compared to analyst estimates of $476.24 million. During the same quarter last year, the firm posted $0.88 earnings per share. The business’s revenue for the quarter was up 27.7% compared to the same quarter last year. equities research analysts anticipate that MKS Instruments will post 5.89 EPS for the current year.

In related news, CFO Seth H. Bagshaw sold 7,500 shares of the stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $85.80, for a total value of $643,500.00. Following the completion of the transaction, the chief financial officer now owns 21,615 shares in the company, valued at approximately $1,854,567. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Brian Charles Quirk sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $107.90, for a total value of $215,800.00. Following the sale, the vice president now owns 13,785 shares of the company’s stock, valued at $1,487,401.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,913 shares of company stock valued at $1,104,039. Company insiders own 1.65% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in MKSI. Riverhead Capital Management LLC raised its stake in shares of MKS Instruments by 71.9% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,063 shares of the scientific and technical instruments company’s stock valued at $139,000 after acquiring an additional 863 shares in the last quarter. Krilogy Financial LLC bought a new position in MKS Instruments in the 3rd quarter worth approximately $144,000. Creative Planning increased its position in MKS Instruments by 22.8% in the 2nd quarter. Creative Planning now owns 2,239 shares of the scientific and technical instruments company’s stock worth $151,000 after buying an additional 416 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of MKS Instruments by 12.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,482 shares of the scientific and technical instruments company’s stock worth $167,000 after purchasing an additional 281 shares in the last quarter. Finally, Good Life Advisors LLC acquired a new stake in shares of MKS Instruments during the 2nd quarter worth approximately $203,000. Hedge funds and other institutional investors own 95.47% of the company’s stock.

WARNING: This article was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/12/03/valuengine-downgrades-mks-instruments-mksi-to-hold.html.

About MKS Instruments

MKS Instruments, Inc is a global provider of instruments, subsystems and process control solutions that measures, controls, powers, delivers, monitors and analyzes critical parameters of advanced manufacturing processes. The Company operates through two segments, including the Vacuum & Analysis segment and the Light & Motion segment.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for MKS Instruments Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments Inc. and related companies with MarketBeat.com's FREE daily email newsletter.